Loading...
01/11 03:22
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The company exhibits strong financial health with increased cash reserves and reduced liabilities. Strategic investments in partnerships and technology development are promising. The Q&A indicates optimism in quantum security and international expansion. The partnership with POET Technologies and increased shareholder equity are positive signals. However, lack of specific guidance on M&A targets and share count could cause slight uncertainty. Overall, the positive aspects outweigh the negatives, suggesting a positive stock price movement.
Revenue Revenue during the third quarter totaled approximately $384,000 compared to $101,000 in the same period last year, representing a significant increase. The increase was primarily due to increases in the number, size, and level of effort on research and development services contracts and custom hardware contracts. Additionally, revenue was recognized for cloud-based access to the DIRAC-3 quantum optimization system.
Gross Margin Gross margin for the third quarter increased to 33% compared to 9% in the third quarter of 2024. The improvement was attributed to a small number of active contracts, some of which involved custom design work, though gross margin is expected to remain variable due to the nature of these contracts.
Operating Expenses Operating expenses for the third quarter totaled $10.5 million compared to $5.4 million in the same quarter last year, reflecting a substantial increase. This was due to growth in personnel for research and development, engineering, manufacturing, sales and marketing, and administration to support long-term growth.
Net Income The company reported net income of $2.4 million for the third quarter, or approximately $0.01 per share, compared to a net loss of $5.7 million in the third quarter of 2024. The increase in net income was primarily due to a gain of $9.2 million from the mark-to-market of a derivative liability and interest income of $3.5 million.
Cash and Cash Equivalents As of September 30, 2025, cash and cash equivalents increased by $273 million to $352 million compared to year-end 2024. This increase was driven by a $500 million equity financing closed in September 2025.
Investments Total investments increased by $460 million as of September 30, 2025, contributing to the company's strengthened financial position.
Total Liabilities Total liabilities at the end of the third quarter were $20 million, a decrease of approximately $26 million compared to year-end 2024. This decrease was primarily driven by a $25.8 million reduction in the derivative liability related to the QPhoton merger warrants.
Stockholders' Equity Stockholders' equity rose to $878 million at the end of the third quarter, reflecting the company's strengthened financial position.
DIRAC-3 quantum optimization machine: Used in NASA LiDAR initiative to remove solar noise from space-based LiDAR data, showcasing real-world applications in scientific and environmental fields.
EmuCore reservoir computing device: Sold to a global automotive manufacturer and a major U.S. financial institute, validating its quantum AI and security platforms in real-world settings.
Government and commercial sectors: Growing adoption of quantum and photonic solutions across research, enterprise, and government sectors.
Fab 1 and Fab 2 facilities: Fab 1 is operational for small-scale manufacturing of thin-film lithium niobate photonic chips, while planning for Fab 2 to support higher volume manufacturing is underway.
Manufacturing strategy: Focused on refining processes, scaling small batch production, and expanding team and facilities to transition towards volume production by the end of the decade.
Revenue growth: Revenue increased to $384,000 in Q3 2025 from $101,000 in Q3 2024, driven by R&D services and custom hardware contracts.
Capital raised: Raised $1.5 billion in 2025, including $500 million in Q3 and $750 million post-Q3, to fund engineering, manufacturing, and sales initiatives.
Industry engagement: Active participation in industry events and memberships in organizations like the Quantum Economic Development Consortium to enhance visibility and influence.
Engineering and Manufacturing Execution: The company faces challenges in transitioning from prototype and small-batch manufacturing to volume production. This requires refining processes, scaling production, and expanding facilities and teams, which could pose operational risks.
Supply Chain and Facility Expansion: The development of Fab 2 for higher volume manufacturing is in early planning stages and will require significant investment and coordination. Any delays or inefficiencies could impact the company's ability to meet growing demand.
Financial Variability: Gross margins are variable due to the small number of active contracts and custom design work, which could lead to financial unpredictability.
Operational Costs: Operating expenses have increased significantly due to growth in personnel and scaling efforts, which could strain financial resources if revenue growth does not keep pace.
Market Adoption and Competition: While the company has a first-mover advantage in integrated photonics, broader market adoption and competition in the quantum computing sector remain challenges. Competitors focusing on scalability and stability could pose threats.
Regulatory and Government Engagement: The company is involved in government programs and contracts, which may be subject to regulatory changes or funding uncertainties, potentially impacting revenue and operations.
Revenue Growth: The company expects future growth supported by a healthy pipeline of sales and partnership opportunities as customer adoption of its products and technologies increases.
Manufacturing Expansion: QCi plans to transition from prototype and small batch manufacturing to volume production by the end of the decade. The current 3-year roadmap focuses on refining processes, scaling small batch production, and expanding team and facilities. Planning for Fab 2, a higher volume manufacturing facility, is expected to begin within the next 3 years.
Capital Deployment: The company has raised significant capital ($1.5 billion in 2025) to support strategic investments in engineering, manufacturing, and sales. This includes advancing TFLN fabrication and quantum machine development initiatives.
Market Positioning: QCi aims to leverage its integrated photonics platform to address scalability and stability challenges in the quantum computing sector. The company is positioned to deliver energy-efficient, room-temperature quantum devices at scale, which are critical for next-generation computing.
Strategic Partnerships and Acquisitions: The company is evaluating acquisition opportunities to accelerate its vision of making quantum technology widely accessible.
The selected topic was not discussed during the call.
The company exhibits strong financial health with increased cash reserves and reduced liabilities. Strategic investments in partnerships and technology development are promising. The Q&A indicates optimism in quantum security and international expansion. The partnership with POET Technologies and increased shareholder equity are positive signals. However, lack of specific guidance on M&A targets and share count could cause slight uncertainty. Overall, the positive aspects outweigh the negatives, suggesting a positive stock price movement.
The company faces challenges with declining revenue, increasing operating expenses, and a significant net loss. Despite some positive aspects like improved gross margins and a strengthened capital position, the risks related to strategic execution, market adoption, and competitive pressures overshadow these. The Q&A insights on milestones and hiring plans do not mitigate concerns about revenue variability and financial stability. Given these factors, the stock is likely to experience a negative reaction in the short term.
The earnings call summary reveals strong financial performance, with significant net income and asset growth. Product development and market expansion efforts, like the NASA subcontract and sales to major institutions, are promising. However, the Q&A highlights some uncertainties, such as vague responses on capacity constraints and future foundry plans. Despite lower gross margins, the optimistic outlook, strategic partnerships, and robust financial position suggest a positive sentiment. The lack of specific shareholder return plans slightly tempers this, but overall, the company's trajectory appears positive for short-term stock movement.
The earnings call highlights a strong financial performance with a significant net income turnaround and increased cash reserves. The strategic partnership with NASA and sales to notable institutions bolster the positive outlook. Despite some operational and competitive risks, the overall sentiment is buoyed by strong financial health and promising market expansion plans. The Q&A reveals potential growth, albeit with vague timelines. The positive elements, such as net income and strategic partnerships, outweigh the risks, leading to a predicted stock price increase of 2% to 8%.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
